Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve Adults
Clinical trial NCT01366534 · COMPLETED
Trial details
- NCT number
- NCT01366534
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-10
- Primary completion
- 2012-02-27
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.